Federated Hermes’s Ocugen OCGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-383
Closed -$380 2156
2024
Q3
$380 Buy
+383
New +$526 ﹤0.01% 2007
2023
Q4
Sell
-5,374
Closed -$2.15K 2157
2023
Q3
$2.15K Hold
5,374
﹤0.01% 1963
2023
Q2
$2.92K Buy
+5,374
New +$3.45K ﹤0.01% 1963
2023
Q1
Sell
-104,035
Closed -$135K 2219
2022
Q4
$135K Buy
104,035
+93,710
+908% +$146K ﹤0.01% 1607
2022
Q3
$19K Buy
10,325
+8,893
+621% +$22.1K ﹤0.01% 1775
2022
Q2
$3K Sell
1,432
-1,160
-45% -$2.77K ﹤0.01% 1950
2022
Q1
$9K Buy
+2,592
New +$9.11K ﹤0.01% 1898

Other funds holding OCGN

Federated Hermes's OCGN Position: Q4 2024 in Review

Federated Hermes sold out of Ocugen (OCGN) in Q4 2024, closing a stake of 383 shares — an estimated $380 sold.

Federated Hermes first reported a position in OCGN in Q1 2022 and held it in 7 quarters. The position peaked at $135K in Q4 2022. 114 funds tracked by Wall St. Rank hold OCGN as of Q4 2024.

  • Federated Hermes reported no remaining Ocugen position as of Q4 2024 after selling out during the quarter.
  • Federated Hermes sold 383 Ocugen shares in Q4 2024, an estimated $380.
  • Federated Hermes first reported a position in Ocugen in Q1 2022 and held it in 7 quarters.
  • Federated Hermes's Ocugen position peaked at $135K in Q4 2022.
  • 114 funds tracked by Wall St. Rank held Ocugen as of Q4 2024.

Based on Federated Hermes's 13F filing for Q4 2024, filed 13 Feb 2025.